Marcus S Noel MD
Hematologic Oncology
Medical director of the Clinical Trials Office
Join to View Full Profile
3800 Reservoir Rd NWWashington, DC 20007
Phone+1 202-444-2223
Dr. Noel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014- University of Rochester Medical CenterResidency, Internal Medicine, 2008 - 2011
Rutgers Robert Wood Johnson Medical SchoolClass of 2008
Certifications & Licensure
DC State Medical License 2019 - 2026
VA State Medical License 2021 - 2026
MD State Medical License 2022 - 2025
NY State Medical License 2010 - 2020
American Board of Internal Medicine Medical Oncology
Clinical Trials
- APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers Start of enrollment: 2017 Oct 06
- A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer Start of enrollment: 2021 Mar 08
Roles: Principal Investigator
Publications & Presentations
PubMed
- A phase II single-arm study of combination pembrolizumab and olaparib in the treatment of patients with advanced biliary tract cancer.Narayanan Sadagopan, Hongkun Wang, Chao Yin, Benjamin Adam Weinberg, Marcus Smith Noel
NPJ Precision Oncology. 2025-07-08 - TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors.Ruth Plummer, Mikael H Sodergren, Rose Hodgson, Bríd M Ryan, Nina Raulf
Cell Reports. Medicine. 2025-04-15 - A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers.Andrew H Ko, Joseph Chao, Marcus S Noel, Veena Shankaran, Davendra Sohal
Cancer Research Communications. 2025-02-01
Press Mentions
Let’s Talk About: Pancreatic Cancer’s Impact on Black AmericansFebruary 4th, 2022- ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GIJanuary 24th, 2022
- ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic CancerAugust 24th, 2021
- Join now to see all
Grant Support
- National Capital Area (NCA) Minority/Underserved NCORPGEORGETOWN UNIVERSITY2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
